bpc 157 clinical trials humans safety efficacy Benefits: Heal & Thrive in 2025 BPC-157 for athletes and injury

K., Low, T

These are illustrative, not a contraindication checklist there is no contraindication table because there is no approved indication: Known or suspected malignancy the proposed pro-angiogenic mechanism (particularly via VEGFR2-Akt-eNOS signaling) raises theoretical concerns about tumor vascularization that have not been characterized in humans Pregnancy or breastfeeding no human reproductive or developmental toxicology data exists Known peptide hypersensitivity or a history of serious peptide-related adverse reactions Athletes subject to anti-doping testing BPC-157 is prohibited by WADA under S0 in-competition and out-of-competition

Original context of discovery in human gastric juice research

Those with a history of kidney disease should discuss their options with our healthcare provider, as this medication may have implications for kidney function

Its stable and works well to treat Vitamin B12 deficiency

They also make accurate dosing impossible since part of the measured powder consists of non-peptide material